# A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients

> **NCT03950414** · PHASE1 · TERMINATED · sponsor: **University of Wisconsin, Madison** · enrollment: 2 (actual)

## Conditions studied

- Cytomegalovirus Infections
- Solid Organ Transplant

## Interventions

- **BIOLOGICAL:** CMV specific T-cells

## Key facts

- **NCT ID:** NCT03950414
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-09-27
- **Primary completion:** 2022-07-11
- **Final completion:** 2022-07-11
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Insufficient Patient Population
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03950414

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03950414, "A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Solid Organ Transplant Recipients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03950414. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*